ArticleAcademic pediatrics2026
Trends in Adolescent Depression and Suicide Risk Screening and Symptom Monitoring in a Large Primary Care Network.
Article in Academic pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo examine long-term trends in adolescent depression and suicide risk screening and interim symptom monitoring in pediatric primary care (PC) following implementation of universal screening at well-visits.
methodsThis retrospective cohort study examined electronic health record (EHR) data from 406,192 well-visits of 12 to 17-year-old pediatric patients from 2018 to 2024 in a large PC network in the United States. Screening was conducted using the Patient Health Questionnaire-9: Modified for Teens (PHQ-9-M). We evaluated trends over time in well-visit screening compliance, depression and suicide risk rates, and rates and timing of interim symptom monitoring between well-visits.
resultsScreening compliance improved from 82.1% to 96.0% (χ²
conclusionsIn the years following implementation of universal depression and suicide risk screening in a large PC network, screening compliance increased significantly. However, low rates of interim symptom monitoring for patients screening positive indicate a gap in secondary prevention. Improving risk-based follow-up procedures, including interim screening, in PC represents a critical next step to enhance the preventive potential of universal screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.